OneMedPlace announced today that the Wallace H. Coulter Foundation will be an anchor sponsor of the 5th Annual OneMedForum to be held January 9th to 12th in San Francisco, California. The foundation was formed by the late founder of The Coulter Corporation (now Beckman Coulter) to advance biomedical innovation.
OneMedPlace announced today that the Wallace H. Coulter Foundation will be an anchor sponsor of the 5th Annual OneMedForum to be held January 9th to 12th in San Francisco, California. The foundation was formed by the late founder of The Coulter Corporation (now Beckman Coulter) to advance biomedical innovation.
“We are delighted to have the active participation of the Coulter Foundation in our 5th Annual Forum,” said Brett Johnson, CEO of OneMedPlace. “Their participation enables us to deliver on our goal to showcase the most promising companies and technologies in the world of health and medicine. This will be the first time they have showcased the output of an initiative that began 5 years ago with grants to 10 leading universities to develop a new approach to moving innovation from universities to the marketplace.”
The results of their approach have been impressive. To date, Coulter has funded more than 200 projects. To date, 27 startups have garnered over $150 million in venture capital funding and dozens more have attracted project specific governmental grants totaling several hundred million dollars. 28 products have been licensed by leading firms.
“The results speak for themselves with regard to the significance that this approach brings,” added Johnson. “They have developed a powerful process matching the best qualities of industry and academia to accelerate the commercialization of promising technologies. We are truly excited about showcasing these technologies for our business development and venture investors who look to the OneMedForum as a place that aggregates the most promising companies and ideas in health and medicine.”
“We are pleased to utilize the OneMedPlace platform and their successful investment forum in San Francisco,” said Elias Caro, VP of Technology at the Coulter Foundation. “We are excited to showcase the best projects from our network of universities. More than 100 projects are still moving forward, all of which have been vetted by leading investors, scientists, regulatory and industry experts. They have solid IP and meet significant unmet market needs, and only need to find the right partner.“
OneMedRadio conducted an interview with Caro in which he explains, in greater detail, the Coulter process and the techniques that have made this process successful. It can be accessed at www.onemedplace.com. Caro spent over 25 years at Coulter and most recently was responsible for commercial operations worldwide for Beckman Coulter. The company, which makes laboratory instruments, had 2010 revenue in excess of $3.6 billion and 12,000 employees worldwide.
About the Wallace H. Coulter Foundation
Wallace Coulter’s deepest passion was to improve health care and make these improvements available and affordable to everyone. Prior to his death Mr. Coulter established the Wallace H. Coulter Foundation to fund these areas.The Foundation received funding in December, 1999 and will continue this legacy by funding translational research in biomedical engineering with the goal of accelerating the introduction of new technologies into patient care. Prior to the establishment of its two main programs to support translational research in biomedical engineering, the Foundation began working with colleges, universities and professional associations that Wallace Coulter was associated with during his lifetime. His values of endless curiosity, continuous learning, teamwork, consideration and respect for the individual, coupled with the highest level of ethics and integrity are the cornerstone values of The Wallace H. Coulter Foundation.
About OneMedForum
Founded in 2008, OneMedForum events are held biannually in San Francisco in January and in New York in June. They are designed to create a communications platform for emerging companies to connect with strategic partners and investors.
